15269313 |
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
Bleiberg, H,
Humblet, Y,
Mueser, M,
Khayat, D,
Chau, I,
Cunningham, D,
Bets, D,
Verslype, C,
Santoro, A,
Harstrick, A,
Siena, S,
Van Cutsem, E
|
N Engl J Med |
2004 |
20033049 |
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Zhou, W,
Eck, MJ,
Cortot, AB,
Jänne, PA,
Capelletti, M,
Li, D,
Padera, R,
Engen, JR,
Chen, L,
Chirieac, L,
Gray, NS,
Iacob, RE,
Wong, KK,
Yun, CH,
Ercan, D
|
Nature |
2009 |
15837620 |
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
Ferguson, KM,
Wiltzius, JJW,
Schmitz, KR,
Li, S,
Kussie, P,
Jeffrey, PD
|
Cancer Cell |
2005 |